Skip to content

Comparison of continuous femoral nerve block combined with other methods for postoperative analgesia after total knee arthroplasty

Comparison of continuous femoral nerve block combined with other methods for postoperative analgesia after total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015079
Enrollment
Unknown
Registered
2018-03-06
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia Total knee replacement

Interventions

1:local injection only
2:simple continuous nerve block
3:continuous unit nerve block combined with local injection

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American anesthesiologist class I to III, elective unilateral total knee arthroplasty in 90 patients with adult osteoarthritis. Prior to the patient's admission to the hospital, a written informed consent form of eligible volunteer participation trials is given to inform training about the contents of the trial, including the anatomy of the surface of the anterior and posterior knees, which is used to demonstrate the difference between knees (Corresponding to the innervation of the femoral nerve) and the area behind the knee (corresponding to the sciatic nerve).

Exclusion criteria

Exclusion criteria: Aged less than 18 or older; body mass index greater than 35 kg / m2; pregnancy; failure to provide informed consent; may affect assessment of cognitive or psychiatric history; refusal of spinal anesthesia, femoral nerve block; Narcotic or multimodal analgesic hyperalgesia or multimodal analgesia; preexisting neuropathy or neurological dysfunction lower limbs; preexisting chronic pain or other conditions requiring long-term use of oxycodone at a dose of 30 mg daily or Equivalent; have taboo peripheral or central nervous block, such as coagulation disorders or bleeding tendency.

Design outcomes

Primary

MeasureTime frame
analgesic effect;

Secondary

MeasureTime frame
early functional recovery;serum C-reactive protein;deep venous thrombosis of lower extremities;

Contacts

Public ContactShitai Wang

Gansu Provincial Hospital of TCM

wangshitai1974@163.com+86 13893467902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026